EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Monitoring Complete Blood Counts and Haemoglobin Levels in Osteoarthritis Patients: Results from a European Survey Investigating Primary Care Physician Behaviours and Understanding

Chris Walker, Augusto Faustino, Angel Lanas

The Open Rheumatology Journal · 19.12.2014 · 8 (1) · 110-115

DOI: 10.2174/1874312901408010110 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Open Rheumatology Journal, erschienen am 19.12.2014. Verfasst von Chris Walker und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pfizer Ltd, Walton on-the-Hill, Tadworth, Surrey, UK. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic use of non-steroidal anti-inflammatory drugs (NSAIDs) is associated with an increased risk of gastrointestinal (GI) toxicity, including occult blood loss and the development of clinically significant anaemia.

Methods

700 primary care physicians who routinely used NSAIDs to manage their patients were questioned to probe their understanding of the potential importance of blood loss in the OA populations they commonly treated with NSAIDs in a chronic fashion.

Results

Approximately 50% of doctors surveyed measured their osteoarthritis patients’ haemoglobin routinely as part of a complete blood count (CBC). The remaining cohort of physicians only considered conducting CBCs if they believed there was cause for concern, with the most common reasons cited being anaemia/blood loss (90/80% of physicians respectively) or the patient showing signs of weakness and fatigue (78% of physicians). When all doctors were queried on their understanding of normal range of haemoglobin (Hb) values, as defined by the WHO, significant variation in the absolute figures were reported with approximately 40% of physicians citing a low end range for normal that would actually place the patient below the threshold for anaemia.

Conclusion

Physician practice in relation to carrying out blood tests in OA patients and their understanding of the potential significance of specific results obtained, namely haemoglobin values, varies substantially across the countries surveyed. As NSAIDs form a pivotal part in the chronic treatment of osteoarthritis and are well recognised agents that can precipitate blood loss, guidelines may be needed to advise physicians as to when monitoring a patient’s haemoglobin levels may be appropriate.

Schlagwörter

Stichwörter der Autor:innen

Blood lossGINSAIDsosteoarthritis.

Autor:innen und Institutionen

  • Pfizer Ltd, Walton on-the-Hill, Tadworth, Surrey, UK.
  • Clínica de Reumatologia de Lisboa, Lisboa, Portugal; Instituto Português de Reumatologia de Lisboa, Lisboa, Portugal.
  • University of Zaragoza, Aragón Health Research Institute (IIS Aragón), CIBERehd, Zaragoza, Spain.

Zitieren

APA

Walker, C., Faustino, A., & Lanas, A. (2014). Monitoring Complete Blood Counts and Haemoglobin Levels in Osteoarthritis Patients: Results from a European Survey Investigating Primary Care Physician Behaviours and Understanding. The Open Rheumatology Journal, 8(1), 110-115. https://doi.org/10.2174/1874312901408010110

Vancouver

Walker C, Faustino A, Lanas A. Monitoring Complete Blood Counts and Haemoglobin Levels in Osteoarthritis Patients: Results from a European Survey Investigating Primary Care Physician Behaviours and Understanding. The Open Rheumatology Journal. 2014;8(1):110-115. doi:10.2174/1874312901408010110

BibTeX
@article{Walker2014,
  author = {Walker, Chris and Faustino, Augusto and Lanas, Angel},
  title = {Monitoring Complete Blood Counts and Haemoglobin Levels in Osteoarthritis Patients: Results from a European Survey Investigating Primary Care Physician Behaviours and Understanding},
  journal = {The Open Rheumatology Journal},
  year = {2014},
  volume = {8},
  number = {1},
  pages = {110--115},
  doi = {10.2174/1874312901408010110}
}
Kostenlos starten →